|
US2021002307A1
|
|
Crystal Forms of Crisaborole In Free Form And Preparation Method And Use Thereof
|
|
WO2018160845A1
|
|
Novel oxaborole analogs and uses thereof
|
|
NZ748502A
|
|
Oxaborole esters and uses thereof
|
|
PE20190119A1
|
|
OXABOROL ESTERS AND THEIR USES
|
|
EP3423159A1
|
|
Boron-containing small molecules
|
|
US2019077814A1
|
|
Boron-containing small molecules
|
|
CN108366958A
|
|
Topical pharmaceutical formulation for treating inflammatory-related disorders
|
|
BR112017021380A2
|
|
compound, combination, pharmaceutical formulation, method of extermination and / or prevention of growth of a protozoan, and use of compound
|
|
AU2015202701A1
|
|
Boron-containing small molecules as anti-inflammatory agents
|
|
JP2015178508A
|
|
Boron-containing small molecule as antiinflammatory agent
|
|
WO2015042532A1
|
|
Boron-containing small molecules as anti-inflammatory agents
|
|
WO2015013318A1
|
|
Boron-containing small molecules
|
|
JP2015212249A
|
|
Compounds and nail polish
|
|
WO2014121124A1
|
|
Boron-containing small molecules as antiprotozoal agents
|
|
WO2013154759A1
|
|
Benzoxaborole compounds and uses thereof
|
|
WO2014007831A1
|
|
Boron-containing small molecules
|
|
CN103140228A
|
|
Benzoxaborole derivatives for treating bacterial infections
|
|
WO2011150190A2
|
|
Hcv inhibitor compounds and methods of use thereof
|
|
WO2011116348A1
|
|
Boron-containing small molecules as anti-protozoal agent
|
|
WO2011094450A1
|
|
Boron-containing small molecules
|
